Yahoo Web Search

Search results

  1. People also ask

  2. Jean-Charles Soria is a Professor of Medicine and Medical Oncology at South-Paris University. He is a tenure-track and full-time cancer specialist at Institut Gustave Roussy. Dr Soria trained as a medical oncologist and obtained the Silver medal from Paris Medical School in 1997.

  3. Jean-Charles Soria is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy, where he was appointed director general by France’s minister of health and solidarity.

  4. Mar 1, 2014 · Phase I trials now play an essential role in treating patients with metastatic cancer, offering vital extra moves in the battle to outplay the disease, says Jean-Charles Soria. He warns, however, that not every patient wants to play every move, at any cost.

  5. Dr. Soria is the chief executive officer of Gustave Roussy Cancer Center, the premier European comprehensive cancer center based in Villejuif, France, a position to which he was appointed in January 2020.

    • Scientific Advisor
    • Gritstone Bio, Gritstone Bio
  6. Dr. Soria is senior vice president of research and development oncology at AstraZeneca. He leads the cross-functional teams responsible for the strategy, growth and advancement of the early oncology biologics portfolio, which includes immuno-oncology, cell therapy and antibody drug conjugates.

  7. Professor Jean-Charles Soria. General Director of Gustave Roussy from January 2020 to august 2021. Professor Jean-Charles Soria is a Medical Oncologist and Professor of Medicine at Paris-Saclay University. He holds a doctorate in molecular biology.

  8. Sep 3, 2019 · Dr Daniel Soria has joined the University of Kent as a Lecturer in the School of Computing. Daniel will be a member of the Data Science Research Group and will be based at the Medway campus.

  1. People also search for